
Self-Employment Linked to Lower Heart Disease Risk
New study suggests self-employment may reduce the risk of heart disease.
Every 33 seconds, someone in the U.S. dies from cardiovascular disease, according to the CDC. Yet a new 2025 UCLA analysis of 20,000 working adults finds that self-employment, especially for women, is linked to significantly lower rates of obesity, inactivity, and poor sleep, three of the biggest drivers of heart trouble. Here's what that means for anyone considering self-employment, including a side hustle, gig work, or simply pushing for more flexibility in their day job.
The UCLA study used data from the National Health and Nutrition Examination Survey (NHANES), a rigorous national dataset that combines in-person exams, objective health measures, and detailed questionnaires. Researchers analyzed factors such as body mass index (BMI), blood pressure, exercise frequency, and sleep patterns, providing a comprehensive view of participants' heart health.
Here's what the researchers discovered:
Why might self-employment boost women's health? The study's authors and outside experts point to the job-demand-control model—a theory that suggests autonomy (control over tasks and schedules) buffers against job stress and its physiological effects.
'There is a relationship between self-employment and heart disease risk factors and this relationship seems to be stronger in women relative to men,' said lead author Dr. Kimberly Narain, assistant professor-in-residence of medicine at the David Geffen School of Medicine at UCLA. 'It is imperative to increase our understanding of how the work environment gets under our skin so we can come up with ways to ensure that everyone has access to a healthy work environment.'
Research from Harvard and other institutions consistently finds that high job control is associated with better cardiovascular outcomes, especially for women.
Consider what a typical day looks like for someone self-employed:
By contrast, traditional employment often involves stricter schedules, mandatory meetings, and fewer opportunities to tailor work to one's well-being.
While women enjoyed clear benefits, the study found that men did not experience the same heart health advantages from self-employment. In fact, Black and Hispanic men who were self-employed had similar or even worse risk profiles than their employed peers.
Experts suggest several possible explanations:
This nuance matters because self-employment is not a universal cure-all, and policies to support healthier work should be mindful of structural and demographic differences.
Heart disease remains the top killer of American women, but it's also among the most preventable. According to the CDC, small changes in weight, activity, and sleep can dramatically lower risk. Employers who care about the well-being—and long-term productivity—of their teams can make a difference by:
If you're self-employed, or thinking about it ,you can maximize the health benefits of autonomy with a few mindful steps:
The science is clear. Autonomy at work isn't just about productivity or job satisfaction. It could be a literal lifesaver. If you've ever considered a side hustle, self-employment, or simply pushing for more flexibility in your day job, now is the time. Your heart may thank you for it.
1. What is the connection between self-employment and heart disease risk?
Research suggests that self-employed women experience lower rates of obesity, physical inactivity, and insufficient sleep, all major heart disease risk factors, compared to traditionally employed women.
2. Does self-employment improve heart health for men, too?
The 2025 UCLA study found that self-employed men did not experience the same heart health benefits as women, and results varied significantly by race and ethnicity.
3. What explains the health advantage for self-employed women?
Experts believe increased autonomy and schedule flexibility allow self-employed women to prioritize physical activity, sleep, and healthy habits, reducing their heart disease risk.
4. Are there downsides to self-employment for health?
Self-employment can bring financial instability, stress, and, for some, reduced access to healthcare or social support, so not all aspects are beneficial for health.
5. What other research supports these findings?
A 2023 Harvard study published in the American Journal of Public Health linked job autonomy and flexible work arrangements to lower rates of hypertension and cardiovascular events.
6. What can employers do to help employees reduce heart disease risk?
Offering flexible hours, true results-based work, and health-supportive benefits can help all employees adopt heart-healthy behaviors.
7. How can self-employed workers protect their heart health?
Experts recommend building financial stability, scheduling regular exercise and sleep, prioritizing preventive care, and maintaining social connections for long-term well-being.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Ascletis Announces Poster Presentations on the Study Results of ASC30 and ASC47 at the 85th Scientific Sessions of American Diabetes Association (ADA)
HONG KONG, June 8, 2025 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces that poster presentations on preliminary studies of its oral small molecule GLP-1 Receptor (GLP-1R) agonist ASC30 and adipose-targeted, muscle-preserving weight loss drug candidate ASC47 will be presented at the 85th Scientific Sessions of American Diabetes Association (ADA) in Chicago, U.S. Details of the Poster Presentations Poster Number: 750-P Abstract Title: ASC30, an Oral GLP-1R Biased Small Molecule Agonist in Participants with Obesity—A First-in-Human Single Ascending Dose Study Session Type: General Poster Session Location: Poster Hall (Hall F1) Presentation Time: Sunday Jun 22, 2025 12:30 PM - 1:30 PM (Chicago Time), i.e., Monday Jun 23, 2025 1:30 AM - 2:30 AM (Beijing Time) Poster Number: 847-P Abstract Title: ASC47, a Muscle-Preserving Weight Loss Drug Candidate for Obesity, in Combination with Semaglutide, Demonstrated Superior Weight Loss to Semaglutide Monotherapy in a Preclinical Model Session Type: General Poster Session Location: Poster Hall (Hall F1) Presentation Time: Sunday Jun 22, 2025 12:30 PM - 1:30 PM (Chicago Time), i.e., Monday Jun 23, 2025 1:30 AM - 2:30 AM (Beijing Time) About ASC30 ASC30 is an investigational GLP-1R biased small molecule agonist and has unique and differentiated properties that enable the same small molecule for both oral tablet and subcutaneous injection administrations. ASC30 is a new chemical entity (NCE), with U.S. and global compound patent protection until 2044. About ASC47 ASC47 is an adipose-targeted, ultra-long-acting subcutaneously (SQ) injected thyroid hormone receptor beta (THRβ) selective small molecule agonist, discovered and developed in-house at Ascletis. ASC47 possesses unique and differentiated properties to enable adipose targeting, resulting in dose-dependent high drug concentrations in the adipose tissue. Topline data from its Phase Ib single subcutaneous injection studies in Australia in participants with elevated low-density lipoprotein cholesterol (LDL-C) (NCT06427590) have been released. The Phase I clinical trial of ASC47 in combination with semaglutide for the treatment of obesity (NCT06972992) is ongoing in the U.S., and the first participants were dosed in May 2025. About the American Diabetes Association (ADA) Established in 1940, the American Diabetes Association (ADA) is dedicated to preventing and curing diabetes and to improving the lives of all people affected by diabetes. It has grown into one of the foremost nonprofit organizations in diabetes advocacy around the world. Its annual Scientific Sessions set the agenda for clinical practice and research innovation. The 85th Scientific Sessions of ADA will be held in Chicago, U.S. from June 20 to 23, 2025. About Ascletis Pharma Inc. Ascletis is an innovative R&D driven biotech listed on the Hong Kong Stock Exchange ( covering the entire value chain from discovery and development to GMP manufacturing. Led by a management team with deep expertise and a proven track record, Ascletis is focused on metabolic diseases by addressing unmet medical needs from a global perspective. Ascletis has multiple clinical stage drug candidates in its metabolic disease pipeline. For more information, please visit Contact: Peter Vozzo ICR Healthcare 443-231-0505 (U.S.) Ascletis Pharma Inc. PR and IR teams +86-181-0650-9129 (China) pr@ ir@ View original content: SOURCE Ascletis Pharma Inc. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data


New York Post
3 hours ago
- New York Post
Simple tool could detect Parkinson's disease early — it was 96% accurate in experiments
This pen truly is mightier than the sword. A team of researchers at UCLA has developed a high-tech diagnostic pen that can detect signs of Parkinson's disease with over 96% accuracy, offering a low-cost way to identify the neurodegenerative disorder far earlier than now. A pilot study in the journal Nature Chemical Engineering unveiled the device, which looks much like a regular pen. 3 A patient with PD using the diagnostic pen for a writing task. Nature Chemical Engineering It's able pick up on subtle motor dysfunctions before they're visible to the naked eye, all by analyzing how people write. So, how does this futuristic fountain pen work? The tip is made of a flexible silicone material infused with magnetic particles, and it writes using a special ferrofluid ink that contains nanomagnets. As someone writes, pressure from the hand deforms the tip, causing changes in magnetic fields that produce electrical signals — like a Morse code of motor function. Those signals are then analyzed to detect the difference between healthy and Parkinson's-affected motor patterns. In tests with 16 participants — including 3 with Parkinson's — the system nailed the diagnosis with 96.22% accuracy. Even more impressive? The pen worked whether people wrote on paper or in the air, meaning it doesn't even require a surface. 3 Nature Chemical Engineering Today, Parkinson's is largely diagnosed based on observations, which are subjective, or by biomarker-based imaging, which can be expensive. This diagnostic pen is portable, inexpensive and doesn't rely on a neurologist to interpret results, making it a promising option for remote screenings, home use or even telehealth checkups. 'Our development of the diagnostic pen represents a low-cost, widely disseminable and reliable technology with the potential to improve PD diagnostics across large populations and resource-limited areas,' the researchers wrote. With further validation in a larger population, the device could be used not just for early diagnosis, but for ongoing symptom tracking and personalized treatment monitoring. 3 Today, Parkinson's is largely diagnosed based on observations, which are subjective, or by biomarker-based imaging, which can be expensive. highwaystarz – This is just the latest innovation aimed at tackling Parkinson's disease, which affects more than 10 million people worldwide and has no known cure. A recent study found that psilocybin — the psychedelic compound that gave 'magic mushrooms' their trippy reputation in the 1960s — showed serious promise for improving mood and motor function in people with Parkinson's disease. Tavapadon — a new drug that mimics dopamine by targeting certain receptors — has also shown promise in clinical trials by reducing motor fluctuations and maintaining symptom control with fewer side effects than traditional therapies. Produodopa — a continuous infusion therapy first administered in the UK — was approved by the US Food and Drug Administration last fall. Innovative approaches targeting the psychological aspects of the disease have been successful as well — with tandem cycling proving to be especially popular. Some New Yorkers even find relief by playing pingpong.
Yahoo
3 hours ago
- Yahoo
The Tastiest Side Dish At Panda Express Is Actually One Of The Healthiest Things On The Menu
Panda Express is practically synonymous with mall crawls and quick eats. If you're looking for low-carb fast food options that won't ruin your diet, the choices can seem few and far between; however, there are still a handful of nutritious dishes among Panda's offerings. Tasting Table set out to determine the definitive rankings of Panda Express' menu items and stumbled upon a runner-up to its ubiquitous orange chicken that packs a punch of lean, green deliciousness. Panda Express super greens are nothing short of heroic and can be ordered as a health-conscious side dish, entree, or kid's meal. Though fast food vegetables can seem like a gamble as far as taste and quality, the mix of kale, cabbage, and broccoli is tossed in a sauce that's been seasoned to perfection, providing nutritional benefits without skimping on the flavor. Per Tasting Table's assessment, the super greens maintain a balanced consistency between crisp and tender, and the garlic sauce is reminiscent of a home-cooked meal. The wholesome nutritional value offers 7 grams of dietary fiber and 9 grams of protein per 10-ounce serving, both of which help to promote gut health, longevity, and healthy muscles. The dish is also lower in sugar, fat, and sodium in comparison to the dishes you should think twice about ordering. Panda Express fans certainly echo this positive sentiment, praising the dish for its simplicity in preparation and big flavor. Read more: 13 Chinese Restaurant Chains, Ranked Worst To Best A thoughtful mix of green vegetables in a light and aromatic sauce, Panda Express super greens are not only a go-to order for Panda customers, but also for employees. Many have tried to suss out what it is about the sauce that makes it so crave-worthy, and the truth is actually much simpler than you might imagine. Whereas copycat recipes attempt to replicate the dish by sauteeing the veggies in a neutral oil, and tossing them with minced garlic, ginger, and soy sauce, Panda Express employees have mentioned the sauce is primarily made of a powdered vegetable soup mix diluted in oil with an additional pinch of salt and garlic in which the blanched vegetables are tossed. You can easily make your own version of the dish at home, though it will not taste exactly like the Panda Express menu item you know and love. Whether you're venturing out for a fast food treat or making your own veggie side dish, remember that the key to any healthy dish is keeping your ingredients simple and preparation methods effective. And the next time you're tossed between steamed rice and chow mein, try pivoting towards a greener alternative. You might find yourself pleasantly surprised. Read the original article on Tasting Table.